The UK is experiencing a remarkable shift in its understanding towards mind-altering substances. What began with a subtle exploration of psilocybin and commonplace ceremonial brews is increasingly expanding to include lesser-known substances like copyright and though studies into clinical uses. This burgeoning interest is fuelled by a combination o